南美洲和中美洲神经血管设备市场预测至 2027 年 - COVID-19 影响和按产品划分的区域分析（神经血栓切除术设备、动脉瘤弹簧圈和栓塞设备、脑球囊血管成形术和支架系统以及支持设备）；应用（脑动脉瘤、缺血性中风、动静脉畸形和瘘管以及其他应用）；最终用户（医院、门诊手术中心和专科诊所）和国家/地区
No. of Pages: 94 | Report Code: TIPRE00016221 | Category: Life Sciences
No. of Pages: 94 | Report Code: TIPRE00016221 | Category: Life Sciences
神经血管装置用于治疗可能影响大脑周围血管网络的神经血管疾病。神经血管疾病会导致中风和动脉瘤等无法治愈的疾病。神经血管装置用于预防中风、动脉瘤栓塞、颈动脉狭窄和其他症状。神经血管装置还用于进行外科手术，以治疗动脉瘤和其他颅血流问题。
南部和南部地区中美洲神经血管器械市场预计将从 2019 年的 1.814 亿美元增至 2027 年的 2.2408 亿美元。预计 2020-2027 年该市场的复合年增长率为 2.8%。 推动南美洲和中美洲神经血管设备市场增长的关键因素是神经血管疾病发病率的增加、对微创手术的需求不断增加以及人口老龄化显着增长。然而，由于栓塞线圈成本高、缺乏操作神经血管疾病的专业人士等因素，预计市场增长速度将放缓。
南美洲和中美洲 神经血管设备市场，根据产品细分为神经血栓切除设备、动脉瘤弹簧圈和神经血管设备。栓塞装置、脑球囊血管成形术和支架系统和支撑装置。动脉瘤旋绕术栓塞设备在 2019 年占据了最大的市场份额，预计在预测期内将实现市场最高的复合年增长率。
南美洲和中美洲 神经血管设备市场根据应用进行了细分脑动脉瘤、缺血性中风、动静脉畸形等瘘管和其他应用。 2019 年，缺血性中风细分市场占据最大市场份额，预计在预测期内将实现最高的复合年增长率。
根据最终用户，< /span>南美洲和中美洲神经血管设备市场分为医院、门诊手术中心和专科诊所。 2019年，医院细分市场占据最大市场份额，并且预计在预测期内以最高复合年增长率主导市场。
包括南美洲和中美洲神经血管设备市场的一些主要一级和二级来源报告中包括： Brazilian 神经科学与神经技术研究所 (BRAINN)；圣保罗研究基金会 (FAPESP)； 世界银行；世界中风组织（WSO）；和世界卫生组织（WHO）；
南美洲和中美洲北美神经血管设备市场 -
作者 产品
按应用
由最终用户< /p>
按国家
公司简介
Strategic insights for South and Central America Neurovascular Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 181.40 Million |
| Market Size by 2027 | US$ 224.08 Million |
| Global CAGR (2020 - 2027) | 2.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South and Central America Neurovascular Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Neurovascular Devices Market is valued at US$ 181.40 Million in 2019, it is projected to reach US$ 224.08 Million by 2027.
As per our report South and Central America Neurovascular Devices Market, the market size is valued at US$ 181.40 Million in 2019, projecting it to reach US$ 224.08 Million by 2027. This translates to a CAGR of approximately 2.8% during the forecast period.
The South and Central America Neurovascular Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Neurovascular Devices Market report:
The South and Central America Neurovascular Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Neurovascular Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Neurovascular Devices Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Neurovascular Devices Market
